Attitudes on clinical research participation of community living elders in Korea

Cheolmin Shin, Moon Ho Park, Changsu Han, Ashwin A. Patkar, Byung-Joo Ham, Seung Hyun Kim, Sook Haeng Joe, Chi Un Pae, In Kwa Jung

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Introduction: The development of medical knowledge has involved increasing numbers of clinical studies, including trials of treatment modalities among elderly individuals. We evaluated knowledge about and attitudes on participation in various clinical trials among elderly individuals. Methods: A semi-structured survey was developed and distributed to community-living elders who agreed to participate in the Ansan Geriatric Study. Survey items addressed (i) the process of acquiring consent, (ii) the advantages of participation in clinical trials, (iii) worries about participation, (iv) clinical field trials in which they would like to participate, and (v) reasons behind participation. Results: A total of 361 individuals (158 women and 203 men, mean age 71.1 years) agreed to answer the survey about clinical trials. The reported advantages of participation in clinical trials were access to cost-free medication or interventions (44.9%), prevention or early diagnosis of possible future diseases (23.8%), diagnostic and laboratory tests at no charge (14.7%), and contribution to human wellbeing (13.3) The reported disadvantages were the possibility of side-effects from the new treatments (32.1%), giving blood for frequent laboratory tests (28.5%), concerns about intrusions on human dignity (9.9%), and possible leakage of personal identifying data (8.6%). An additional 10.8% saw no disadvantages. Subjects were interested in participating in clinical field trials for interventions or medication to treat metabolic syndrome and medical diseases (43.5%), Alzheimer's and Parkinson's diseases (11.1%), late-life depression (2.5%). Although more than two-thirds (77.3%) of the subjects believed that they should provide consent for themselves, some believed that their spouses (14.4%) or other family members (8.3%) should be able to receive the explanation of the clinical trial and sign the informed consent forms. Discussion: We should consider the attitudes of elderly participants during the processes of explaining clinical trials and acquiring consent.

Original languageEnglish
Pages (from-to)168-173
Number of pages6
JournalAsia-Pacific Psychiatry
Volume4
Issue number3
DOIs
Publication statusPublished - 2012 Sep 1

Fingerprint

Korea
Clinical Trials
Research
Personhood
Consent Forms
Community Participation
Spouses
Routine Diagnostic Tests
Geriatrics
Parkinson Disease
Early Diagnosis
Alzheimer Disease
Depression
Costs and Cost Analysis
Therapeutics
Surveys and Questionnaires

Keywords

  • Attitude
  • Clinical trial
  • Elder
  • Informed consent
  • Survey

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Attitudes on clinical research participation of community living elders in Korea. / Shin, Cheolmin; Park, Moon Ho; Han, Changsu; Patkar, Ashwin A.; Ham, Byung-Joo; Kim, Seung Hyun; Joe, Sook Haeng; Pae, Chi Un; Jung, In Kwa.

In: Asia-Pacific Psychiatry, Vol. 4, No. 3, 01.09.2012, p. 168-173.

Research output: Contribution to journalArticle

Shin, Cheolmin ; Park, Moon Ho ; Han, Changsu ; Patkar, Ashwin A. ; Ham, Byung-Joo ; Kim, Seung Hyun ; Joe, Sook Haeng ; Pae, Chi Un ; Jung, In Kwa. / Attitudes on clinical research participation of community living elders in Korea. In: Asia-Pacific Psychiatry. 2012 ; Vol. 4, No. 3. pp. 168-173.
@article{9725973b4667463d8d4d228761eb07aa,
title = "Attitudes on clinical research participation of community living elders in Korea",
abstract = "Introduction: The development of medical knowledge has involved increasing numbers of clinical studies, including trials of treatment modalities among elderly individuals. We evaluated knowledge about and attitudes on participation in various clinical trials among elderly individuals. Methods: A semi-structured survey was developed and distributed to community-living elders who agreed to participate in the Ansan Geriatric Study. Survey items addressed (i) the process of acquiring consent, (ii) the advantages of participation in clinical trials, (iii) worries about participation, (iv) clinical field trials in which they would like to participate, and (v) reasons behind participation. Results: A total of 361 individuals (158 women and 203 men, mean age 71.1 years) agreed to answer the survey about clinical trials. The reported advantages of participation in clinical trials were access to cost-free medication or interventions (44.9{\%}), prevention or early diagnosis of possible future diseases (23.8{\%}), diagnostic and laboratory tests at no charge (14.7{\%}), and contribution to human wellbeing (13.3) The reported disadvantages were the possibility of side-effects from the new treatments (32.1{\%}), giving blood for frequent laboratory tests (28.5{\%}), concerns about intrusions on human dignity (9.9{\%}), and possible leakage of personal identifying data (8.6{\%}). An additional 10.8{\%} saw no disadvantages. Subjects were interested in participating in clinical field trials for interventions or medication to treat metabolic syndrome and medical diseases (43.5{\%}), Alzheimer's and Parkinson's diseases (11.1{\%}), late-life depression (2.5{\%}). Although more than two-thirds (77.3{\%}) of the subjects believed that they should provide consent for themselves, some believed that their spouses (14.4{\%}) or other family members (8.3{\%}) should be able to receive the explanation of the clinical trial and sign the informed consent forms. Discussion: We should consider the attitudes of elderly participants during the processes of explaining clinical trials and acquiring consent.",
keywords = "Attitude, Clinical trial, Elder, Informed consent, Survey",
author = "Cheolmin Shin and Park, {Moon Ho} and Changsu Han and Patkar, {Ashwin A.} and Byung-Joo Ham and Kim, {Seung Hyun} and Joe, {Sook Haeng} and Pae, {Chi Un} and Jung, {In Kwa}",
year = "2012",
month = "9",
day = "1",
doi = "10.1111/j.1758-5872.2012.00177.x",
language = "English",
volume = "4",
pages = "168--173",
journal = "Asia-Pacific Psychiatry",
issn = "1758-5864",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Attitudes on clinical research participation of community living elders in Korea

AU - Shin, Cheolmin

AU - Park, Moon Ho

AU - Han, Changsu

AU - Patkar, Ashwin A.

AU - Ham, Byung-Joo

AU - Kim, Seung Hyun

AU - Joe, Sook Haeng

AU - Pae, Chi Un

AU - Jung, In Kwa

PY - 2012/9/1

Y1 - 2012/9/1

N2 - Introduction: The development of medical knowledge has involved increasing numbers of clinical studies, including trials of treatment modalities among elderly individuals. We evaluated knowledge about and attitudes on participation in various clinical trials among elderly individuals. Methods: A semi-structured survey was developed and distributed to community-living elders who agreed to participate in the Ansan Geriatric Study. Survey items addressed (i) the process of acquiring consent, (ii) the advantages of participation in clinical trials, (iii) worries about participation, (iv) clinical field trials in which they would like to participate, and (v) reasons behind participation. Results: A total of 361 individuals (158 women and 203 men, mean age 71.1 years) agreed to answer the survey about clinical trials. The reported advantages of participation in clinical trials were access to cost-free medication or interventions (44.9%), prevention or early diagnosis of possible future diseases (23.8%), diagnostic and laboratory tests at no charge (14.7%), and contribution to human wellbeing (13.3) The reported disadvantages were the possibility of side-effects from the new treatments (32.1%), giving blood for frequent laboratory tests (28.5%), concerns about intrusions on human dignity (9.9%), and possible leakage of personal identifying data (8.6%). An additional 10.8% saw no disadvantages. Subjects were interested in participating in clinical field trials for interventions or medication to treat metabolic syndrome and medical diseases (43.5%), Alzheimer's and Parkinson's diseases (11.1%), late-life depression (2.5%). Although more than two-thirds (77.3%) of the subjects believed that they should provide consent for themselves, some believed that their spouses (14.4%) or other family members (8.3%) should be able to receive the explanation of the clinical trial and sign the informed consent forms. Discussion: We should consider the attitudes of elderly participants during the processes of explaining clinical trials and acquiring consent.

AB - Introduction: The development of medical knowledge has involved increasing numbers of clinical studies, including trials of treatment modalities among elderly individuals. We evaluated knowledge about and attitudes on participation in various clinical trials among elderly individuals. Methods: A semi-structured survey was developed and distributed to community-living elders who agreed to participate in the Ansan Geriatric Study. Survey items addressed (i) the process of acquiring consent, (ii) the advantages of participation in clinical trials, (iii) worries about participation, (iv) clinical field trials in which they would like to participate, and (v) reasons behind participation. Results: A total of 361 individuals (158 women and 203 men, mean age 71.1 years) agreed to answer the survey about clinical trials. The reported advantages of participation in clinical trials were access to cost-free medication or interventions (44.9%), prevention or early diagnosis of possible future diseases (23.8%), diagnostic and laboratory tests at no charge (14.7%), and contribution to human wellbeing (13.3) The reported disadvantages were the possibility of side-effects from the new treatments (32.1%), giving blood for frequent laboratory tests (28.5%), concerns about intrusions on human dignity (9.9%), and possible leakage of personal identifying data (8.6%). An additional 10.8% saw no disadvantages. Subjects were interested in participating in clinical field trials for interventions or medication to treat metabolic syndrome and medical diseases (43.5%), Alzheimer's and Parkinson's diseases (11.1%), late-life depression (2.5%). Although more than two-thirds (77.3%) of the subjects believed that they should provide consent for themselves, some believed that their spouses (14.4%) or other family members (8.3%) should be able to receive the explanation of the clinical trial and sign the informed consent forms. Discussion: We should consider the attitudes of elderly participants during the processes of explaining clinical trials and acquiring consent.

KW - Attitude

KW - Clinical trial

KW - Elder

KW - Informed consent

KW - Survey

UR - http://www.scopus.com/inward/record.url?scp=84865548643&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865548643&partnerID=8YFLogxK

U2 - 10.1111/j.1758-5872.2012.00177.x

DO - 10.1111/j.1758-5872.2012.00177.x

M3 - Article

VL - 4

SP - 168

EP - 173

JO - Asia-Pacific Psychiatry

JF - Asia-Pacific Psychiatry

SN - 1758-5864

IS - 3

ER -